| Lymphoma subtypes in India: a tertiary care center review S Jain, MR Lone, A Goswami, T Mandal, AK Panda, P Ramteke, ... Clinical and Experimental Medicine 21, 315-321, 2021 | 11 | 2021 |
| NFκB (RelA) mediates transactivation of hnRNPD in oral cancer cells V Kumar, A Kumar, M Kumar, MR Lone, D Mishra, SS Chauhan Scientific Reports 12 (1), 5944, 2022 | 8 | 2022 |
| Follicular Helper T-Cell–derived Nodal Lymphomas: Study of Histomorphologic, Immunophenotypic, Clinical, and RHOA G17V Mutational Profile S Jain, A Goswami, MR Lone, P Ramteke, A Gogia, M Aggarwal, ... Applied Immunohistochemistry & Molecular Morphology 31 (3), 172-180, 2023 | 3 | 2023 |
| The expression of the RUVBL1 component of the R2TP complex correlates with poor prognosis in DLBCL M Lone, M Shadang, Q Akhter, M Kumar, S Mallick, A Gogia, N Nilima, ... Pathobiology 89 (3), 146-156, 2022 | 3 | 2022 |
| Genetic analysis of HIBM myopathy-specific GNE V727M hotspot mutation identifies a novel COL6A3 allied gene signature that is also deregulated in multiple neuromuscular … S Attri, M Lone, A Katiyar, V Sharma, V Kumar, C Verma, SK Gahlawat Genes 14 (3), 567, 2023 | 2 | 2023 |
| Clinicopathological profile of primary double expressor lymphoma S Mallick, A Panda, MR Lone, A Goswami, P Ramteke, MC Sharma, ... Clinical Lymphoma, Myeloma and Leukemia 19, S257, 2019 | 2 | 2019 |
| ABCL-299: updated purview of lymphomas in India: a tertiary care centre review S Jain, MR Lone, A Goswami, T Mandai, AK Panda, P Ramteke, ... Clinical Lymphoma Myeloma and Leukemia 20, S272, 2020 | 1 | 2020 |
| ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) in Patients Diagnosed With Primary … I Gupta, MR Lone, P Ramteke, A Gogia, A Upadhyay, S Mallick Clinical Lymphoma Myeloma and Leukemia 22, S382, 2022 | | 2022 |
| Poster: ABCL-523 Immunohistochemical (IHC) Expression of Epigenetic Regulators (EZH-2 and H3K27) as well as Cell Cycle Regulators (P16, P53 and RB) in Patients Diagnosed With … I Gupta, MR Lone, P Ramteke, A Gogia, A Upadhyay, S Mallick Clinical Lymphoma, Myeloma and Leukemia 22, S170, 2022 | | 2022 |
| Evaluation of Heterogeneous Nuclear Ribonucleoprotein D Expression as a Diagnostic Marker for Oral Squamous Cell Carcinoma V Kumar, MR Lone, A Kumar, V Vincent, H Thakkar, D Mishra, ... Diagnostics 12 (6), 1332, 2022 | | 2022 |
| Poster: TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas S Jain, A Goswami, T Mandal, MR Lone, P Ramteke, MC Sharma, ... Clinical Lymphoma Myeloma and Leukemia 21, S248, 2021 | | 2021 |
| TCL-239: Clinical, Pathological, and Prognostic Implications of RHOAG17V Mutation in Peripheral T-Cell Lymphomas S Jain, A Goswami, T Mandal, MR Lone, P Ramteke, MC Sharma, ... Clinical Lymphoma Myeloma and Leukemia 21, S413-S414, 2021 | | 2021 |
| CLINICO‐PATHOLOGICAL PROFILE AND CMYC IMMUNOREACTIVITY OF ALK POSITIVE LARGE B CELL LYMPHOMA: REPORT OF NINE CASES. S Mallick, MR Lone, P Ramteke, S Purokait, A Gogia, A Batra, S Bakhshi, ... Hematological Oncology 35, 395-396, 2017 | | 2017 |
